<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">AID</journal-id><journal-title-group><journal-title>Advances in Infectious Diseases</journal-title></journal-title-group><issn pub-type="epub">2164-2648</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/aid.2020.101001</article-id><article-id pub-id-type="publisher-id">AID-98062</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine&amp;Healthcare</subject></subj-group></article-categories><title-group><article-title>
 
 
  Effects of the Soil-Derived Microorganism BX-1 on Chicken Newcastle Disease
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Kiyotaka</surname><given-names>Murakami</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Kazuhide</surname><given-names>Adachi</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Retno</surname><given-names>Damajanti Soejoedono</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Ekowati</surname><given-names>Handharyani</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Yasuhiro</surname><given-names>Tsukamoto</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib></contrib-group><aff id="aff3"><addr-line>Faculty of Veterinary Medicine, Bogor Agriculture University, Bogor, Indonesia</addr-line></aff><aff id="aff1"><addr-line>R&amp;amp;D Section, Taiga Inc., Tokyo, Japan</addr-line></aff><aff id="aff2"><addr-line>Department of Animal Hygiene, Graduate School of Environmental &amp;amp; Biological Sciences, Kyoto Prefecture University, Kyoto, Japan</addr-line></aff><pub-date pub-type="epub"><day>22</day><month>01</month><year>2020</year></pub-date><volume>10</volume><issue>01</issue><fpage>1</fpage><lpage>10</lpage><history><date date-type="received"><day>28,</day>	<month>December</month>	<year>2019</year></date><date date-type="rev-recd"><day>19,</day>	<month>January</month>	<year>2020</year>	</date><date date-type="accepted"><day>22,</day>	<month>January</month>	<year>2020</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  In recent years, effective microorganisms (EMs) have been administered to humans and domestic animals, and their usefulness has been recognized for promoting health and enhancing immunity. For example, the preventative effects against flu are enhanced by ingestion of 
  <em>Lactobacillus</em> by humans, and symptom relief of atopic dermatitis has been reported, with EMs actually used in commercial products. In addition, EM preparations are being used in livestock to prevent infections (e.g. 
  <em>Salmonella</em> and 
  <em>Escherichia coli</em> infection). In poultry, avian influenza and Newcastle disease are terrible and fatal infectious diseases that cause significant economic damage. Furthermore, countries designated as contaminated with these pathogens can experience major trade problems. Given the above, how to protect livestock from infections safely and at low cost without using disinfectants, antibiotics and vaccines is a major issue. In the present study, we examined whether or not Newcastle disease could be suppressed by feeding chickens BX-1 as an EM feed. A field strain of Newcastle virus was cloned from cloaca swabs of large numbers of dying chickens in a poultry farm in Indonesia by polymerase chain reaction (PCR) and hemaggregation assays. Chicken kidney cells and embryonated eggs were highly sensitive to this virus, and high titers of virus were able to be collected. The experimental viral inoculated to chickens showed a high mortality rate, with high pathogenicity in birds. Conventional chickens were also raised on a diet supplemented with BX-1 and directly infected with the Newcastle virus. The mortality was decreased in these infected birds. Even the low dose of BX-1 had an inhibitory effect on the lethality of the infection. These results suggest that BX-1 intake through an EM diet is effective in controlling Newcastle disease.
 
</p></abstract><kwd-group><kwd>Newcastle Disease</kwd><kwd> Effective Microorganisms</kwd><kwd> BX-1</kwd><kwd> Chicken</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>Newcastle disease (ND) is a viral infection to which various species of bird, including poultry, are susceptible [<xref ref-type="bibr" rid="scirp.98062-ref1">1</xref>]. ND outbreaks occur in many countries, including Japan, and the disease is highly contagious exerting a significant economic impact. In Japan, ND is designated an infectious diseases under the livestock infectious disease prevention law for chickens, ducks, quails and turkeys [<xref ref-type="bibr" rid="scirp.98062-ref2">2</xref>]. Other infectious diseases mentioned in this law for poultry include highly pathogenic avian influenza, poultry cholera and salmonella infections.</p><p>ND was first discovered in 1926 in Southeast Asia but only named when it was rediscovered in 1927 in Newcastle upon Tyne, UK. The pathogen ND virus (NDV) is a single-stranded RNA virus classified into the Paramyxoviridae family along with measles virus, mumps virus, distemper virus, Sendai virus and others. NDV infection occurs through feed, water, equipment and clothing contaminated with feces of affected birds [<xref ref-type="bibr" rid="scirp.98062-ref3">3</xref>]. Symptoms vary greatly depending on the NDV strain, host species, health status and age, among other factors, but common symptoms include those of the respiratory system (dyspnea, cough) and nervous system (depression, loss of appetite, wing weakness, paralysis), swelling of the eyes and neck, diarrhea, abnormal egg shells and decreased egg production [<xref ref-type="bibr" rid="scirp.98062-ref4">4</xref>].</p><p>NDV strains are divided into highly toxic, addictive and attenuated strains. The highly toxic type is further divided into an Asian type and an American toxic type [<xref ref-type="bibr" rid="scirp.98062-ref1">1</xref>]. Severely virulent strains cause serious respiratory and neurological symptoms, are highly infectious and have a mortality rate of over 80%. Addictive strains cause coughing and egg-laying abnormalities, resulting in a mortality rate of about 10%. The mortality of attenuated strains is negligible. Since the countries that use ND vaccines are designated as contaminated countries, their export of poultry products, such as chicken and eggs, to clean countries, such as the USA and Canada, is not permitted. If a novel ND prevention method could be developed instead of a vaccine, the livestock industry would benefit from a trade perspective.</p><p>We established a virus infection prevention method using ostrich antibodies instead of vaccines and antibiotics [<xref ref-type="bibr" rid="scirp.98062-ref5">5</xref>] [<xref ref-type="bibr" rid="scirp.98062-ref6">6</xref>]. In the present study, we attempted to control the viral infection in chickens using effective microorganisms (EMs), a feed additive. In humans, yogurt and beverages containing Lactobacillus stabilize the intestinal microflora and suppress the colonization of pathogens, relieve symptoms of atopic dermatitis and block pathogen infection by enhancing immunity [<xref ref-type="bibr" rid="scirp.98062-ref7">7</xref>] [<xref ref-type="bibr" rid="scirp.98062-ref8">8</xref>] [<xref ref-type="bibr" rid="scirp.98062-ref9">9</xref>] [<xref ref-type="bibr" rid="scirp.98062-ref10">10</xref>]. In livestock, various EM agents are used to promote growth and prevent infectious diseases. In chickens, microbial competitive exclusion has been set for preventing food poisoning caused by Salmonella and E. coli [<xref ref-type="bibr" rid="scirp.98062-ref11">11</xref>] [<xref ref-type="bibr" rid="scirp.98062-ref12">12</xref>] [<xref ref-type="bibr" rid="scirp.98062-ref13">13</xref>].</p><p>As a probiotic, the mixed microorganism agent BX-1, which is mainly composed of Lactobacillus and yeasts removed from soil, has been commercialized (Kawashima Co., Ltd.) [<xref ref-type="bibr" rid="scirp.98062-ref14">14</xref>]. Since BX-1 is a mixture of soil microorganisms, it does not seem to exert the same effect as the natural intestinal microflora; nevertheless, it can still be expected to be useful as a member of the bacterial microflora with many physiological activities that can benefit the living body. BX-1 is a group of aerobic bacteria, and since it is in a dry powder form, it is easy to handle and inexpensive. BX-1 has been suggested not only to suppress the colonization of intestinal pathogens, such as Salmonella and Escherichia coli, but also to enhance the vitality of the living body, particularly the immunity.</p><p>We herein report the results of our infection experiment using a highly pathogenic field strain of NDV obtained from a poultry farm in Indonesia.</p></sec><sec id="s2"><title>2. Materials and Methods</title><p>Newcastle disease virus (ND)</p><p>Swab samples from the cloaca of dying chickens on an Indonesia poultry farm were analyzed. RNA was extracted from the chorioallantoic fluid (CAF) of embryonated chicken eggs and culture media of chicken kidney cells inoculated with the swab samples and ND vaccine strain using a viral RNA extraction kit. Mixtures of 2 μL of RNA, 1 μL of 5-pmol oligo (dT), 4 μL of 5 &#215; RTbuffer, 2 μL of 10 mM dNTPs, 1 μL of Rever-Tra Ace and 10 μL of DEPC water were reverse-transcribed at 42˚C; 60 minutes, 99˚C; 5 minutes and further, 15˚C. Polymerase chain reaction (PCR) was carried out using cDNA, 2 μl of the cDNA, 12.5 μl of 2 &#215; pre-mix Taq, 9.5 μl of sterilized distilled water and 1 μl of NDV F1/M1 primer (F1: 5’ CAT-CTT-CCC-AAC-TGC-CAC-TG 3’, M1: 5’ TTC-TCT- AGC-AGT-GGG-ACA-GC 3’) [<xref ref-type="bibr" rid="scirp.98062-ref2">2</xref>] under the following conditions: 94˚C for 7 minutes and 34 amplification rounds at 94˚C for 30 seconds, 55˚C for 1 minute and 72˚C for 1 minute, annealing at 72˚C for 7 minutes and then held at 4˚C. The PCR product was used for electrophoresis on an agarose gel with a 100-bp ladder.</p><p>Hemaggregation test</p><p>The blood samples from chickens were mixed with an equal volume of Alseba solution and centrifuged at 2000 rpm for 7 minutes. The supernatant was removed, and Alseba solution was added again; the mixture was then centrifuged at 2000 rpm for 7 min. The washed blood cells were added to phosphate-buffered saline (PBS) to prepare an erythrocyte solution. The serial dilution of virus solution of the NDV vaccine and farm strain was added to a round-bottom 96-well microplate, and then prepared erythrocytes were placed in each well and incubated at room temperature with pre-immune antibody or anti-NDV antibody for 45 minutes.</p><p>Infection experiments in chicken kidney cells</p><p>The viral solution of NDV farm strain in Dulbecco’s modified medium was added to chicken kidney cells (CKs), and the cytopathic effect (CPE) in the cultures was examined at 48 h post-viral inoculation.</p><p>Infection experiment in embryonated eggs</p><p>A 100-&#181;L aliquot of the virus solution of NDV farm strain was injected into the 10-day-old embryonated eggs, and viability was judged 72 h later. The CAF was sampled and used for the in vivo infection examination in chickens.</p><p>NDV infection experiment using chickens</p><p>Ten white Leghorn male chicks at 10 days old were inoculated intranasally with 8 HA of NDV farm strain. The birds were raised under free water and feeding conditions in a BSL-2 facility, and the mortality rate was confirmed by the 10th day. For histopathology, the organs were removed from dying chickens, fixed in formalin, embedded in paraffin, sectioned at 3 μm and stained with Hematoxylin-Eosin (HE) according to the conventional method. Thereafter, the sections were examined under a microscope.</p><p>Effects of BX-1 intake in chickens infected with NDV farm strain</p><p>BX-1 powder mixed at 0.02%, 0.2% and 2% (w/w) in commercial chicken formula feed was fed to 10-day-old white leghorn chickens. Over 10 individuals were used for each BX-1 formulation dose. As control animals, other chickens were fed the same commercial diet without BX-1 powder (0%). At one week of BX-1 feeding, 8 HA of the NDV farm strain was been inoculated intranasally into each chicken. These animals were raised under free water and feeding conditions in a BSL-2 facility, and the mortality rate was confirmed by the 10th day.</p></sec><sec id="s3"><title>3. Results</title><p>Organisms in BX-1</p><p>The species of organisms in BX-1 were confirmed by a third-party laboratory in Japan and listed in <xref ref-type="table" rid="table1">Table 1</xref>. Various microorganisms were found in BX-1, with the Staphylococcus group dominant.</p><p>Newcastle virus</p><p>Embryo deaths were observed in all of the eggs inoculated with cloaca swabs of dying chickens from an Indonesian poultry farm. In addition, when inoculated into CK, the typical CPE appeared in culture cells. PCR using primers specific to NDV showed that the pathogen obtained from the chicken farm in Indonesia was Newcastle virus: An assumed 957-bp single band was detected in both the farm samples and vaccine strain used as a positive control (<xref ref-type="fig" rid="fig1">Figure 1</xref>). In addition, the solution from farm could aggregate the chicken erythrocytes which were inhibited by the addition of anti-NDV antibody (<xref ref-type="fig" rid="fig2">Figure 2</xref>). Over 80% of chickens died following intra-nasal inoculation of the CAF. Histopathologically, ND-specific findings, such as severe acute pneumonia and tracheitis, myocarditis and acute enteritis, were observed (<xref ref-type="fig" rid="fig3">Figure 3</xref>). Accordingly, the pathogens obtained from the Indonesian poultry farm were confirmed to be a highly pathogenic strain of NDV.</p><table-wrap-group id="1"><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Micro-organisms in BX-1</title></caption><table-wrap id="1_1"><table><tbody><thead><tr><th align="center" valign="middle" >Taxon name</th><th align="center" valign="middle" >colony Count/dish</th><th align="center" valign="middle" >Proportion (%)</th></tr></thead><tr><td align="center" valign="middle" >Staphylococcus saprophyticus group</td><td align="center" valign="middle" >12,400</td><td align="center" valign="middle" >59.5524</td></tr><tr><td align="center" valign="middle" >Staphylococcus kloosii</td><td align="center" valign="middle" >6787</td><td align="center" valign="middle" >32.5953</td></tr><tr><td align="center" valign="middle" >Weissella paramesenteroides group</td><td align="center" valign="middle" >432</td><td align="center" valign="middle" >2.0747</td></tr><tr><td align="center" valign="middle" >Staphylococcus aureus group</td><td align="center" valign="middle" >272</td><td align="center" valign="middle" >1.3063</td></tr><tr><td align="center" valign="middle" >Kocuria koreensis</td><td align="center" valign="middle" >246</td><td align="center" valign="middle" >1.1814</td></tr><tr><td align="center" valign="middle" >Staphylococcus pettenkoferi group</td><td align="center" valign="middle" >148</td><td align="center" valign="middle" >0.7108</td></tr><tr><td align="center" valign="middle" >Bacillus cereus group</td><td align="center" valign="middle" >110</td><td align="center" valign="middle" >0.5283</td></tr><tr><td align="center" valign="middle" >Leuconostoc pseudomesenteroides group</td><td align="center" valign="middle" >67</td><td align="center" valign="middle" >0.3218</td></tr><tr><td align="center" valign="middle" >Pediococcus acidilactici group</td><td align="center" valign="middle" >24</td><td align="center" valign="middle" >0.1153</td></tr><tr><td align="center" valign="middle" >Kocuria kristinae</td><td align="center" valign="middle" >19</td><td align="center" valign="middle" >0.0912</td></tr><tr><td align="center" valign="middle" >Staphylococcus sciuri group</td><td align="center" valign="middle" >15</td><td align="center" valign="middle" >0.0720</td></tr><tr><td align="center" valign="middle" >Corynebacterium variabile group</td><td align="center" valign="middle" >14</td><td align="center" valign="middle" >0.0672</td></tr><tr><td align="center" valign="middle" >Enterococcus italicus group</td><td align="center" valign="middle" >14</td><td align="center" valign="middle" >0.0672</td></tr><tr><td align="center" valign="middle" >Brachybacterium faecium group</td><td align="center" valign="middle" >11</td><td align="center" valign="middle" >0.0528</td></tr><tr><td align="center" valign="middle" >Brevibacterium DL489154_s</td><td align="center" valign="middle" >10</td><td align="center" valign="middle" >0.0480</td></tr><tr><td align="center" valign="middle" >Leuconostoc mesenteroides group</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" >0.0384</td></tr><tr><td align="center" valign="middle" >Corynebacterium nuruki group</td><td align="center" valign="middle" >7</td><td align="center" valign="middle" >0.0336</td></tr><tr><td align="center" valign="middle" >Citricoccus muralis group</td><td align="center" valign="middle" >5</td><td align="center" valign="middle" >0.0240</td></tr><tr><td align="center" valign="middle" >Corynebacterium flavescens</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >0.0192</td></tr><tr><td align="center" valign="middle" >Corynebacterium minutissimum group</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >0.0192</td></tr><tr><td align="center" valign="middle" >Enterococcus faecium group</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >0.0192</td></tr><tr><td align="center" valign="middle" >Bacillus megaterium group</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >0.0144</td></tr><tr><td align="center" valign="middle" >Lactobacillus acidipiscis</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >0.0144</td></tr><tr><td align="center" valign="middle" >Lactococcus lactis group</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >0.0144</td></tr><tr><td align="center" valign="middle" >Actinomyces slackii</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >0.0096</td></tr><tr><td align="center" valign="middle" >Arthrobacter agilis group</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >0.0096</td></tr><tr><td align="center" valign="middle" >Arthrobacter echini</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >0.0096</td></tr><tr><td align="center" valign="middle" >Blautia wexlerae</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >0.0096</td></tr><tr><td align="center" valign="middle" >Clavibacter michiganensis group</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >0.0096</td></tr><tr><td align="center" valign="middle" >Kocuria rhizophila group</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >0.0096</td></tr><tr><td align="center" valign="middle" >Neomicrococcus lactis</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >0.0096</td></tr><tr><td align="center" valign="middle" >Ruminococcus faecis</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >0.0096</td></tr><tr><td align="center" valign="middle" >Actinomyces provencensis group</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0.0048</td></tr><tr><td align="center" valign="middle" >Anaerostipes hadrus group</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0.0048</td></tr><tr><td align="center" valign="middle" >Bacillus carboniphilus group</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0.0048</td></tr><tr><td align="center" valign="middle" >Bacillus smithii</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0.0048</td></tr><tr><td align="center" valign="middle" >Bifidobacterium adolescentis group</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0.0048</td></tr><tr><td align="center" valign="middle" >Blautia faecis</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0.0048</td></tr><tr><td align="center" valign="middle" >Brevibacterium iodinum group</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0.0048</td></tr></tbody></table></table-wrap><table-wrap id="1_2"><table><tbody><thead><tr><th align="center" valign="middle" >Caenibacillus caldisaponilyticus</th><th align="center" valign="middle" >1</th><th align="center" valign="middle" >0.0048</th></tr></thead><tr><td align="center" valign="middle" >Caldibacillus debilis</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0.0048</td></tr><tr><td align="center" valign="middle" >Corynebacterium tuberculostearicum</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0.0048</td></tr><tr><td align="center" valign="middle" >Corynebacterium xerosis group</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0.0048</td></tr><tr><td align="center" valign="middle" >Dorea formicigenerans</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0.0048</td></tr><tr><td align="center" valign="middle" >Enterococcus saccharolyticus group</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0.0048</td></tr><tr><td align="center" valign="middle" >Fusicatenibacter saccharivorans</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0.0048</td></tr><tr><td align="center" valign="middle" >Geobacillus stearothermophilus group</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0.0048</td></tr><tr><td align="center" valign="middle" >Geobacillus thermoleovorans group</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0.0048</td></tr><tr><td align="center" valign="middle" >Geobacillus toebii group</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0.0048</td></tr><tr><td align="center" valign="middle" >Kurthia zopfii group</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0.0048</td></tr><tr><td align="center" valign="middle" >Lactobacillus dextrinicus</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0.0048</td></tr><tr><td align="center" valign="middle" >Lactobacillus sakei group</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0.0048</td></tr><tr><td align="center" valign="middle" >Lactococcus taiwanensis</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0.0048</td></tr><tr><td align="center" valign="middle" >Listeria grayi</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0.0048</td></tr><tr><td align="center" valign="middle" >Dorea PAC000479_s</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0.0048</td></tr><tr><td align="center" valign="middle" >Sporobacter PAC001162_s</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0.0048</td></tr><tr><td align="center" valign="middle" >Sporobacter PAC001306_s</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0.0048</td></tr><tr><td align="center" valign="middle" >PAC001201_g PAC002029_s</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0.0048</td></tr><tr><td align="center" valign="middle" >Romboutsia timonensis</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0.0048</td></tr><tr><td align="center" valign="middle" >Rummeliibacillus pycnus</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0.0048</td></tr><tr><td align="center" valign="middle" >Staphylococcus succinus group</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0.0048</td></tr><tr><td align="center" valign="middle" >Weissella ghanensis group</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0.0048</td></tr></tbody></table></table-wrap></table-wrap-group><p>Effects of BX-1 intake on ND in chickens</p><p>Viral solution (8 HA) of NDV farm strain was inoculated into the nasal cavity of 10-day-old chickens, and the number of deaths was counted for the next 10 days, with or without BX-1. As a result, the mortality rate of ND-infected chickens drastically changed in the flock fed the BX-1 diet for one week before virus inoculation (<xref ref-type="fig" rid="fig4">Figure 4</xref>). Even the lowest dose of BX-1 at 0.02% exerted an inhibitory effect on mortality. Furthermore, higher doses of BX-1 tended to slow the deaths of birds. Given the lack of any marked differences in the mortality among BX-1 dosages at day 10, implementation of BX-1 for practical use at a poultry farm was considered feasible even at a dose of 0.02%, with consequent cost reduction expected. Since 0.2% - 0.5% BX-1 is used as the commercial products to prevent Salmonella colonization in chicken intestinal tracts, this commercial product is effective on the prevention for chickens by both bacterial and viral infections [<xref ref-type="bibr" rid="scirp.98062-ref14">14</xref>].</p></sec><sec id="s4"><title>4. Discussion</title><p>One particularly interesting and potentially important finding from this study was the observation that BX-1, a soil microbial EM agent, was able to control not only bacterial infections, but also viral infections: the intake of soil bacterial preparation BX-1 reduced the mortality rate of chickens infected with highly pathogenic NDV. Soil bacterial EM preparations can be mass-produced, are excellent for storage and transportation and can be supplied at low cost [<xref ref-type="bibr" rid="scirp.98062-ref13">13</xref>]. Therefore, EM is considered useful as a feed additive for livestock.</p><p>Since ND is a viral disease and thus operates differently from bacterial diseases, the soil bacterial preparations were unlikely to have contributed directly to the suppression of pathogen colonization in the gastrointestinal tract. Soil bacteria might therefore improve the biological function of chickens and suppress viral infection or reduce the disease severity as found in human atrophic dermatitis [<xref ref-type="bibr" rid="scirp.98062-ref9">9</xref>] [<xref ref-type="bibr" rid="scirp.98062-ref10">10</xref>] [<xref ref-type="bibr" rid="scirp.98062-ref14">14</xref>]. Indeed, there have been reports that the intake of lactic acid bacteria suppresses the flu virus, suggesting a relationship between the microflora in the digestive tract and immunity: the ingestion of bacteria is thought to activate natural killer (NK) cells, resulting in the suppression of virus infection and relief of symptoms [<xref ref-type="bibr" rid="scirp.98062-ref7">7</xref>] [<xref ref-type="bibr" rid="scirp.98062-ref8">8</xref>]. More detailed cellular and molecular analyses will be required in order to verify the mechanism underlying the ND-suppressive effects of the soil bacterial group BX-1.</p><p>In nature, birds commonly ingest soil and thereby consume various microorganisms from the environment. In poultry, however, breeding conditions lacking any windows or having only half-windows are becoming increasingly common, and therefore chickens often no longer consume soil. The construction of a ground-based poultry farming system might be useful as a countermeasure against infectious diseases.</p></sec><sec id="s5"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest regarding the publication of this paper.</p></sec><sec id="s6"><title>Cite this paper</title><p>Murakami, K., Adachi, K., Soejoedono, R.D., Handharyani, E. and Tsukamoto, Y. (2020) Effects of the Soil-Derived Microorganism BX-1 on Chicken Newcastle Disease. Advances in Infectious Diseases, 10, 1-10. https://doi.org/10.4236/aid.2020.101001</p></sec><sec id="s7"><title>NOTES</title></sec></body><back><ref-list><title>References</title><ref id="scirp.98062-ref1"><label>1</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Macpherson</surname><given-names> L.W. </given-names></name>,<etal>et al</etal>. (<year>1956</year>)<article-title>Some Observations on the Epizootiology of Newcastle Disease</article-title><source> Canadian Journal of Comparative Medicine and Veterinary Science</source><volume> 20</volume>,<fpage> 155</fpage>-<lpage>168</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.98062-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Mase, M., Imai, K., Sanada, Y., Sanada, N., Yuasa, N., Imada, T., Tsukamoto, K. and Yamaguchi, S. (2002) Phylogenetic Analysis of Newcastle Disease Virus Genotypes Isolated in Japan. Journal of Clinical Microbiology, 40, 3826-3830. https://doi.org/10.1128/JCM.40.10.3826-3830.2002</mixed-citation></ref><ref id="scirp.98062-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Alders, R. and Peter, S. (2001) Controlling Newcastle Disease in Village Chickens: A Field Manual. ACIAR, Canberra.</mixed-citation></ref><ref id="scirp.98062-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Ganar, K., Das, M., Sinha, S. and Kumar, S. (2014) Newcastle Disease Virus: Current Status and Our Understanding. Virus Research, 184, 71-81. https://doi.org/10.1016/j.virusres.2014.02.016</mixed-citation></ref><ref id="scirp.98062-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Adachi, K., Handharyani, E., Sari, D.K., Takama, K., Fukuda, K., Endo, I., Yamamoto, R., Sawa, M., Tanaka, M., Konishi, I. and Tsukamoto, Y. (2008) Development of Neutralization Antibodies against Highly Pathogenic H5N1 Avian Influenza Virus Using Ostrich (Struthio camelus) Yolk. Molecular Medicine Reports, 1, 2003-2009.</mixed-citation></ref><ref id="scirp.98062-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Tsukamoto, Y., Nakano, Y. and Adachi, K. (2018) Protection against Infectious Bronchitis Virus, a Corona Virus Infection, Using Ostrich Antibodies. Health, 10, 1294-1308. https://doi.org/10.4236/health.2018.1010100</mixed-citation></ref><ref id="scirp.98062-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Kinoshita, T., Maruyama, K., Suyama, K., Nishijima, M., Akamatsu, K., Jogamoto, A., Katakami, K. and Saito, I. (2019) The Effects of OLL1073R-1 Yogurt Intake on Influenza Incidence and Immunological Markers among Women Healthcare Workers: A Randomized Controlled Trial. Food &amp; Function, 10, 8129-8136. https://doi.org/10.1039/C9FO02128K</mixed-citation></ref><ref id="scirp.98062-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Kumova, O.K., Fike, A.J., Thayer, J.L., Nguyen, L.T., Mell, J.C., Pascasio, J., Stairiker, C., Leon, L.G., Katsikis, P.D. and Carey, A.J. (2019) Lung Transcriptional Unresponsiveness and Loss of Early Influenza Virus Control in Infected Neonates Is Prevented by Intranasal Lactobacillus rhamnosus GG. PLoS Pathogens, 15, e1008072. https://doi.org/10.1371/journal.ppat.1008072</mixed-citation></ref><ref id="scirp.98062-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Kim, W.K., Jang, Y.J., Han, D.H., Seo, B., Park, S., Lee, C.H. and Ko, G. (2019) Administration of Lactobacillus fermentum KBL375 Causes Taxonomic and Functional Changes in Gut Microbiota Leading to Improvement of Atopic Dermatitis. Frontiers in Molecular Biosciences, 6, 92. https://doi.org/10.3389/fmolb.2019.00092</mixed-citation></ref><ref id="scirp.98062-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Kim, I.S., Lee, S.H., Kwon, Y.M., Adhikari, B., Kim, J.A., Yu, D.Y., Kim, G.I., Lim, J.M., Kim, S.H., Lee, S.S., Moon, Y.S., Choi, I.S. and Cho, K.K. (2019) Oral Administration of β-Glucan and Lactobacillus plantarum Alleviates Atopic Dermatitis-Like Symptoms. Journal of Microbiology and Biotechnology, 29, 1693-1706. https://doi.org/10.4014/jmb.1907.07011</mixed-citation></ref><ref id="scirp.98062-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Weinack, O.M., Snoeyenbos, G.N., Smyser, C.F. and Soerjadai, A.S. (1982) Reciprocal Competitive Exclusion of Salmonella and Escherichia coli by Native Intestinal Microflora of the Chicken and Turkey. Avian Diseases, 26, 585-595. https://doi.org/10.2307/1589905</mixed-citation></ref><ref id="scirp.98062-ref12"><label>12</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bailey</surname><given-names> J.S. </given-names></name>,<etal>et al</etal>. (<year>1987</year>)<article-title>Factors Affecting Microbial Competitive Exclusion in Poultry</article-title><source> Food Technology</source><volume> 41</volume>,<fpage> 88</fpage>-<lpage>92</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.98062-ref13"><label>13</label><mixed-citation publication-type="book" xlink:type="simple">Mead, G.O. and Impey, C.S. (1987) The Present Status of the Nurmi Concept for Reducing Carriage of Food-Poisoning Salmonellae and Other Pathogens in Live Poultry. In: Smulders, F.J.M., Ed., Elimination of Pathogenic Organisms from Meat &amp; Poultry, Elsevier, 57-77.</mixed-citation></ref><ref id="scirp.98062-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">(1997) Effects of BX-1 on Salmonella Infected in Hatched Chickens and Laying Hens. Yamaguchi Institute of Cell Biology, 1-8.</mixed-citation></ref></ref-list></back></article>